金晶，研究員，博士研究生導師，國家高層次青年人才項目獲得者。主持國家重點研發計劃，國家自然科學基金面上項目等多項國家級課題。中國藥理學會呼吸藥理專業委員會副主任委員，中國藥理學會生化與分子藥理學專業委員會委員，中國藥理學會抗炎免疫委員會委員，中國民族醫藥學會藥理與毒理學分會常務理事，中國病理生理學會缺氧與呼吸專業委員會委員，北京環境誘變劑學會青年委員會副主任委員，《藥學學報》和《Acta Pharmaceutica Sinica B》青年編委。

長期從事腫瘤及炎癥等慢性疾病的發病機制研究和創新藥物研發。作為藥理學科負責人，參與完成2個1類新藥獲CFDA 臨床批件；參與完成3項成果轉化。在Nature Cell Biology, Advanced Sciences等發表論文15篇；獲得國內外授權專利22項；主持國家重點研發計劃（2項）、國家自然科學基金等多項課題，參與國家“十二五”、“十三五”重大新藥創制、國家自然科學基金重大項目等多項課題。

久久综合九色欧美综合狠狠_伊人热热久久原色播放WWW_成A人片亚洲日本久久_久久不见久久见免费影院www日本_97久久精品人人做人人爽,又色又爽又黄的视频在线观看,狼群影院视频在线观看高清版,亚洲AV无码精品网站性色,国产乱码久久久久久红粉影视,精品国产乱码久久久久久一区二区,国产精品免费视频网站,国产A级毛片久久久久久精品,一级特黄高清aaaa大片,亚洲中文字幕欧美一区,久久精品国产99久久狂热,黑人巨大精品欧美_黑人巨大精品欧美黑寡妇_黑人巨大精品欧美一区二区_黑人巨大精品欧美一区二区免费_黑人巨大跨种族video_黑人巨大无码中文字幕无码_黑人巨茎大战俄罗斯美女_黑人巨茎大战俄罗斯美女,中文字幕av不卡|亚洲欧美国产另类|天天干在线播放|日韩黄视频|欧美七区|可以免费看毛片的网站|黄色片在线|国产精品96久久久久久

1. Zhaoxin Zhang^#, Shuying Li^#, Fangfei Li^#, Qinyan Shi, Chengyong Tan, Xiaoying Wang, Mi Li, Yunbao Liu*, Jing Jin*, Yong Li*, Shishan Yu*. Meisoindigo Acts as a Molecular Glue to Target PKMYT1 for Degradation in Chronic Myeloid Leukemia Therapy, Adv Sci, 12(21): e2413676. （IF=14.1）

2. Chunyu Zhang^#, Fangfang Lai^#, Hang Gong^#, Shuying Li, Nan Xiang, Liuyi Que, Nina Xue, Mengyao Hao, Enjia Zhou, Xiaojian Wang*, Taigang Liang*, Jing Jin*. A Novel Dual Bruton’s Tyrosine Kinase/Janus Kinase 3 Inhibitor Wj1113 and its Therapeutic Effects on Rheumatoid Arthritis. MedComm, 6(7): e70207. (IF=10.7)

3. Zhenyuan Li^#, Shuying Li^#, Zeyu Xing^#, Quanchang Gu, Rongrong Du, Jianshuang Jiang, Xiang Yuan, Xu Zhang, Xiaoguang Chen, Nina Xue*, Peicheng Zhang*, Jing Jin*, Yanan Yang*. Discovery of Natural Ah Receptor Antagonists from Salvia miltiorrhiza Bunge and Synthesis of Analogs for Tumor Immunotherapy, J Med Chem, 67(2): 1243–1261. (IF=6.8)

4. Mengyao Hao^#, Rong Fu^#, Jun Tai^#, Zhenhuan Tian^#, Xia Yuan, Yang Chen, Mingjin Wang, Huimin Jiang, Ming Ji, Fangfang Lai, Nina Xue, Liping Bai, Yizhun Zhu, Xiaoxi Lv*, Xiaoguang Chen*, Jing Jin*. S1PR1 serves as a viable drug target against pulmonary fibrosis by increasing the integrity of the endothelial barrier of the lung, Acta Pharm Sin B, 13(3): 1110-1127（IF=14.7）

5. Mingjin Wang, Weida Wang, Shen You, Zhenyan Hou, Ming Ji, Nina Xue, Tingting Du, Xiaoguang Chen*, Jing Jin*. ACAT1 deficiency in myeloid cells promotes glioblastoma progression by enhancing the accumulation of myeloid-derived suppressor cells. Acta Pharm Sin B, 13(12): 4733-4747. （IF=14.7）

6. Ruxuan Wang^#, Xiaoyi Yang^#, Shen You, Mengyao Hao, Jianguang Li*, Xiaoguang Chen*, Jing Jin*. Chlorogenic Acid Relieves the Lupus Erythematosus-like Skin Lesions and Arthritis in MRL/lpr Mice, Pharmaceuticals, 15(11): 1327. （IF=5.2）

7. Yaru Kong^#, Mengyao Hao^#, Aiping Chen^#, Tianxing Yi, Ke Yang, Peng Li, Yi Wang, Pengfei Li, Xinbei Jia, Han Qin, Yuwei Qi, Jie Ji*, Jing Jin*, Qian Hua*, Jun Tai*. SymMap database and TMNP algorithm reveal Huanggui Tongqiao granules for Allergic rhinitis through IFN-mediated, Pharmacol Res, 185: 106483 （IF=9.2）

8. Minjian Yang ^#, Huimin Jiang ^#, Zhuo Yang, Xue Liu, Hanyu Sun, Mengyao Hao, Jinping Hu*, Xiaoguang Chen*, Jing Jin*, Xiaojian Wang*. Design, synthesis, and biological evaluation of pyrrolopyrimidine derivatives as novel Bruton's tyrosine kinase (BTK) inhibitor, Eur J Med Chem, 241: 114611. （IF=6.7）

9. Jingbo Zhang ^#, Huimin Jiang ^#, Songwen Lin ^#, Deyu Wu, Hua Tian, Lin Jiang, Yiman Cui, Jing Jin*, Xiaoguang Chen*, Heng Xu*. Design and Optimization of Thienopyrimidine Derivatives as Potent and Selective PI3Kδ Inhibitors for the Treatment of B-Cell Malignancies, J Med Chem, 65(11): 8011-8028.（IF=7.3）

10. Xueju Wei^#, Yue Huo^#, Jingnan Pi^#, Yufeng Gao^#, Shuan Rao ^#, Manman He^#, Qinglv Wei, Peng Song, Yiying Chen, Dongxu Lu, Wei Song, Junbo Liang, Lingjie Xu, Haixia Wang, Guolin Hong, Yuehong Guo, Yanmin Si, Jiayue Xu, Xiaoshuang Wang, Yanni Ma, Shuyang Yu, Dongling Zou*, Jing Jin*, Fang Wang*, Jia Yu*. METTL3 preferentially enhances non-m6A translation of epigenetic factors and promotes tumourigenesi, Nat Cell Biol, 24(8): 1278–1290. （IF=21.3）